Cargando…
Isolated Central Adrenal Insufficiency Due to Nivolumab: A Case Report
Background: Immune checkpoint inhibitors are immunomodulatory antibodies directed against programmed cell death 1 (PD-1), Nivolumab, or cytotoxic T-lymphocyte antigen-4 (CTLA-4) Ipilimumab. They have improved outcomes in patients with advanced cancers including renal cell carcinoma, non-small cell l...
Autores principales: | Rjoob, Hani, Khan, Tayyab S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265911/ http://dx.doi.org/10.1210/jendso/bvab048.1204 |
Ejemplares similares
-
SUN-437 Central Adrenal Insufficiency Unmasked by Pregnancy
por: Araque, Katherine, et al.
Publicado: (2019) -
SUN-308 Central Adrenal Insufficiency Is Rare in Adults with Prader-Willi Syndrome
por: Rosenberg, Anna G W, et al.
Publicado: (2020) -
When Your Pituitary Fails - A Rare Case of Pituitary Dysfunction Due to Nivolumab and Ipilimumab
por: Khan, Areej, et al.
Publicado: (2021) -
SUN-417 Recovery Of Central Adrenal Insufficiency In A Patient With Hypophysitis Secondary To Immune Checkpoint Inhibitors Therapy
por: Thapi, Sahityasri, et al.
Publicado: (2019) -
SAT-446 No Central Adrenal Insufficiency Found in Adults with Prader-Willi Syndrome Tested by Multiple-Dose Metyrapone Test
por: Davidse, Kirsten, et al.
Publicado: (2019)